• World News
  • Politics
  • Stock
  • Investing
  • Editor’s Pick
Time And Sales Reporter
Politics

FDA phasing out some animal testing in ‘win-win’ for ethics and public health: commissioner

by April 10, 2025
April 10, 2025

— The Food and Drug Administration is phasing out an animal testing requirement for antibody therapies and other drugs in favor of testing on materials that mimic human organs, the FDA announced on Thursday. 

‘For too long, drug manufacturers have performed additional animal testing of drugs that have data in broad human use internationally. This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use,’ FDA Commissioner Martin A. Makary, said in comment provided to Fox News Digital. 

 ‘By leveraging AI-based computational modeling, human organ model-based lab testing, and real-world human data, we can get safer treatments to patients faster and more reliably, while also reducing R&D costs and drug prices. It is a win-win for public health and ethics.’ 

The phase-out focuses on ending animal testing in regard to researching monoclonal antibody therapies, which are lab-made proteins meant to stimulate the immune system to fight diseases such as cancer, as well as other drugs, according to the press release. 

Instead, the FDA will encourage testing on ‘organoids,’ which are artificially grown masses of cells, according to the FDA’s press release obtained by Fox Digital. 

‘The FDA will promote the use of lab-grown human ‘organoids’ and organ-on-a-chip systems that mimic human organs – such as liver, heart, and immune organs – to test drug safety. These experiments can reveal toxic effects that could easily go undetected in animals, providing a more direct window into human responses,’ the press release says. 

The FDA will also encourage the use of AI while testing drugs, including building computer modeling that can predict a drug’s behavior, Fox Digital learned. 

The phase-out will include updating its guidelines to recognize research conducted on organoids and through AI.

‘Companies that submit strong safety data from non-animal tests may receive streamlined review, as the need for certain animal studies is eliminated, which would incentivize investment in modernized testing platforms,’ the FDA explained in its press release. 

The FDA is slated to also work with fellow federal agencies, such as the National Institutes of Health, the National Toxicology Program and the Department of Veterans Affairs, to ‘accelerate the validation’ of the new testing standards and will hold a public workshop later this year to further discuss the matter. 

‘For patients, it means a more efficient pipeline for novel treatments. It also means an added margin of safety, since human-based test systems may better predict real-world outcomes. For animal welfare, it represents a major step toward ending the use of laboratory animals in drug testing. Thousands of animals, including dogs and primates, could eventually be spared each year as these new methods take root,’ Makary said. 

This post appeared first on FOX NEWS
previous post
Musk says DOGE set to top $150B in fraud savings in FY 2026
next post
Mexican drug lord convicted in killing of DEA agent Enrique ‘Kiki’ Camarena is freed

Related Posts

Trump launches precision strikes against Iran. Triumph or...

June 22, 2025

Trump earns bipartisan praise for decisive action against...

June 22, 2025

At UN Security Council, Israel’s ambassador slams Iranian...

June 22, 2025

‘Not constitutional’: Congress invokes new War Powers Resolution...

June 22, 2025

PHOTO GALLERY: Trump in Situation Room during Iran...

June 22, 2025

‘She’s wrong’: Trump says Tulsi Gabbard incorrect about...

June 21, 2025







    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.




    Recent Posts

    • Tesla agrees to first deal to build China’s largest grid-scale battery power plant

      June 22, 2025
    • The NASDAQ 100, On The Brink Of A Breakout, Needs Help From This Group

      June 22, 2025
    • Trump launches precision strikes against Iran. Triumph or trap?

      June 22, 2025
    • Trump earns bipartisan praise for decisive action against Iran’s nuclear program

      June 22, 2025
    • PHOTO GALLERY: Trump in Situation Room during Iran strikes

      June 22, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 timeandsalesreporter.com | All Rights Reserved

    Time And Sales Reporter
    • World News
    • Politics
    • Stock
    • Investing
    • Editor’s Pick

    Read alsox

    New poll shows what Americans think of Trump’s...

    February 13, 2025

    Trump will determine if Putin is ‘serious about...

    February 16, 2025

    US will know in ‘matter of weeks’ if...

    April 4, 2025